Department of Pharmaceutical Chemistry, University of Kansas, 2093 Constant Avenue, Lawrence, Kansas 66047, United States.
Dosage Form Design and Development, BioPharmaceutical Development, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland 20878, United States.
Mol Pharm. 2021 Sep 6;18(9):3223-3234. doi: 10.1021/acs.molpharmaceut.1c00043. Epub 2021 Aug 16.
We investigated the discoloration of a highly concentrated monoclonal antibody (mAbZ) in sodium acetate (NaAc) and histidine/lysine (His/Lys) buffer after exposure to visible light. The color change of the mAbZ formulation was significantly more intense in NaAc buffer and developed a characteristic absorbance with a λ of ca. 450 nm. We characterized this photo-chemically generated chromophore by comparison with visible light photo-degradation of a concentrated solution of a model compound for protein Trp residues, -acetyl-l-tryptophan amide (NATA). The photo-degradation of NATA generated a chromophoric product with a λ of ca. 450 nm and UV-vis spectroscopic properties identical to those of the product generated from mAbZ. This product was isolated and analyzed by high-performance liquid chromatography tandem mass spectrometry (HPLC-MS/MS) and H, C, and H-C heteronuclear single-quantum correlation NMR spectroscopy. MS/MS analysis reveals a product characterized by the loss of 33 Da from NATA, referred to as NATA-33. Together, the NMR data suggest that this product may be -(2,4-dihydrocyclopenta[]indol-2-yl)acetamide (structure ) or a tautomer (-).
我们研究了在可见光照射下,高浓度单克隆抗体(mAbZ)在醋酸钠(NaAc)和组氨酸/赖氨酸(His/Lys)缓冲液中的变色情况。mAbZ 制剂在 NaAc 缓冲液中的颜色变化更为明显,并形成了一个特征性的吸收峰,λ 值约为 450nm。我们通过与模型化合物 - 乙酰基-l-色氨酸酰胺(NATA)的浓溶液的可见光光降解进行比较,对这种光化学产生的生色团进行了表征。NATA 的光降解生成了一个具有 λ 值约为 450nm 的生色产物,其紫外可见光谱性质与 mAbZ 生成的产物相同。该产物通过高效液相色谱串联质谱(HPLC-MS/MS)和 H、C 和 H-C 异核单量子相关 NMR 光谱进行了分离和分析。MS/MS 分析表明,该产物的特征是从 NATA 中失去 33Da,称为 NATA-33。NMR 数据表明,该产物可能是 -(2,4-二氢环戊并[]吲哚-2-基)乙酰胺(结构)或互变异构体 (-)。